Increased FGF-19 levels following explantation in women with breast implant illness
Abstract Breast Implant Illness (BII) is characterized by a cluster of systemic and local symptoms affecting a subset of women with silicone breast implants. While symptom improvement is frequently observed following implant removal, the underlying mechanisms remain poorly understood, and the absenc...
Saved in:
Main Authors: | S. Azahaf, K. A. Spit, C. J. M. de Blok, P. W. B. Nanayakkara |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-88013-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Positron Emission Tomography Imaging in Breast Implant Illness
by: Siham Azahaf, MD, et al.
Published: (2025-01-01) -
Patient-reported systemic symptoms in women with silicone breast implants: a descriptive cohort study
by: Karlinde Amber Spit, et al.
Published: (2022-06-01) -
Accidental Explantation of a Cochlear Implant in a Child Who Developed Cholesteatoma as a Late Complication of Cochlear Implantation
by: Wong Kein Low, et al.
Published: (2020-01-01) -
FGF-23 Levels before and after Renal Transplantation
by: Domniki Economidou, et al.
Published: (2009-01-01) -
Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
by: Anke H. Hautmann, et al.
Published: (2014-01-01)